5-Bromo-2H-spiro[benzofuran-3,4'-piperidine] hydrochloride, 97%, 250mg

4-Ethoxycarbonyl-2-fluorophenylisothiocyanate, 98.0%, 5g

4-Biphenylboronic acid, 99.00%, 10g

4-Amino-5-fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one, 95.0%, 25g

4-(Hydroxymethyl)pyridin-3-ol, 97%, 5g

3a,4,5,9b-Tetrahydro-3 H -cyclopenta[ c ]quinoline-4-carboxylic acid, 95.0%, 10g

Ethyl 2-(6-chloropyridazin-3-yl)acetate, 95%, 25g

2,3,4-Trifluorophenyl cyclopropyl ketone, 97.0%, 1g

N,N-Diisopropylethylamine (DIPEA), 250mL, >=99.5%, for peptide synthesis, glass packaging

2-methylbutan-1-ol, 1g

7-Methylguanosine>85.0%(HPLC)(qNMR)1g

2-Chloro-3',4'-(ethylenedioxy)benzophenone, 97.0%, 2g

8-(2-ethoxyphenyl)-8-oxooctanoic acid, 97.0%, 2g